| MLRSX | RGACX | MLRSX / RGACX | |
| Total Expense Ratio | 0.62 | 0.93 | 67% |
| Annual Report Gross Expense Ratio | 0.63 | 0.93 | 68% |
| Fund Existence | 13 years | 24 years | - |
| Gain YTD | -1.490 | 20.558 | -7% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 13.3B | 339B | 4% |
| Annual Yield % from dividends | 0.00 | 0.07 | - |
| Returns for 1 year | -5.78 | 6.27 | -92% |
| Returns for 3 years | 35.69 | 67.13 | 53% |
| Returns for 5 years | -7.69 | 31.42 | -24% |
| Returns for 10 years | 22.04 | 99.84 | 22% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| UPSX | 63.88 | 0.83 | +1.32% |
| Tradr 2X Long UPST Daily ETF | |||
| PPIE | 29.16 | 0.24 | +0.82% |
| Putnam PanAgora ESG Intl Eq ETF | |||
| IBBQ | 28.56 | 0.22 | +0.76% |
| Invesco Nasdaq Biotechnology ETF | |||
| EPEM | 23.87 | N/A | N/A |
| Harbor Emerging Markets Equity ETF | |||
| EOS | 22.84 | -0.23 | -1.00% |
| Eaton Vance Enhance Equity Income Fund II | |||